In the last years numerous reports describing a possible association between administration of vaccines and development of autoimmune phenomena and overt autoimmune disease were published. Possible mechanisms of induction of autoimmune phenomena by vaccines and their excipients are probably similar to those implicated in induction by infectious agents. Here we report the case of an 11-year-old girl who developed autoimmune hepatitis type II after four weeks from vaccination against human papillomavirus. The possible relationships between the use of adjuvated vaccine against papillomavirus and autoimmune hepatitis are discussed. Although we do not provide evidence for a causal link, we suggest that the occurrence of the autoimmune hepatitis may be related to the stimulation of immune system by adjuvated-vaccine, that could have triggered the disease in a genetically predisposed individual. Therefore a monitoring of liver function test following administration of vaccine against papillomavirus may be useful in adolescent girl with signs of hepatopathy, as jaundice, dark urine or hepatomegaly, to early identify and to promptly treat autoimmune liver disorders.

Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl / Della Corte, C; Carlucci, A; Francalanci, P; Alisi, A; Nobili, V.. - In: VACCINE. - ISSN 0264-410X. - 29:29-30(2011), pp. 4654-4656. [10.1016/j.vaccine.2011.05.002]

Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl

Nobili V.
2011

Abstract

In the last years numerous reports describing a possible association between administration of vaccines and development of autoimmune phenomena and overt autoimmune disease were published. Possible mechanisms of induction of autoimmune phenomena by vaccines and their excipients are probably similar to those implicated in induction by infectious agents. Here we report the case of an 11-year-old girl who developed autoimmune hepatitis type II after four weeks from vaccination against human papillomavirus. The possible relationships between the use of adjuvated vaccine against papillomavirus and autoimmune hepatitis are discussed. Although we do not provide evidence for a causal link, we suggest that the occurrence of the autoimmune hepatitis may be related to the stimulation of immune system by adjuvated-vaccine, that could have triggered the disease in a genetically predisposed individual. Therefore a monitoring of liver function test following administration of vaccine against papillomavirus may be useful in adolescent girl with signs of hepatopathy, as jaundice, dark urine or hepatomegaly, to early identify and to promptly treat autoimmune liver disorders.
2011
autoimmune hepatitis; children; hpv vaccination; adjuvants, immunologic; child; female; hepatitis, autoimmune; histocytochemistry; humans; liver; papillomavirus vaccines; molecular medicine; immunology and microbiology (all); veterinary (all); public health, environmental and occupational health; infectious diseases
01 Pubblicazione su rivista::01i Case report
Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl / Della Corte, C; Carlucci, A; Francalanci, P; Alisi, A; Nobili, V.. - In: VACCINE. - ISSN 0264-410X. - 29:29-30(2011), pp. 4654-4656. [10.1016/j.vaccine.2011.05.002]
File allegati a questo prodotto
File Dimensione Formato  
Della Corte_Autoimmune hepatitis_2011.pdf.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 403.66 kB
Formato Adobe PDF
403.66 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1177984
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 19
social impact